Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eli Lilly will offer Guidant stake as split-off:

This article was originally published in Clinica

Executive Summary

Eli Lilly's disposal of its 82%-stake in Guidant will take the form of a split-off - an offer to Lilly shareholders to exchange some or all of their Lilly stock for Guidant shares. This plan had been one of the options outlined when Lilly announced its exit from the medical devices industry in January 1994. The split-off proposal is contained in a registration statement filed with the US Securities and Exchange Commission. Following review by the SEC and depending on market conditions, Guidant expects the split-off to be completed during the autumn this year. Specific terms will be announced at the commencement of the exchange offer, the company adds.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091901

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel